EU MDR and the changing regulatory landscape.

This webinar will dive into the increased specificity of the EU MDR from a biocompatibility perspective and how the revised 10993-1 fits into the new requirements. We will share our experiences from the viewpoint of testing laboratory experts and regulatory consultants with biocompatibility experience from both science and regulatory affairs backgrounds. Our goal is to help you understand the changing regulatory landscape in light of EU MDR, what that means for biocompatibility, and how to ensure your products have adequate evidence.

Approaches for biocompatibility tests such as substances with known carcinogenicity, mutagenicity, and reproductive toxicity for the EU and US regulatory authorities will be covered. We'll go one step further and explore strategies to ensure biocompatibility test results can be leveraged for marketing in multiple geographical regions. We will share several scenarios that will be applicable to small business and big companies alike to demonstrate how manufacturers may leverage clinical evidence to support biocompatibility requirements.

Access the On-Demand Webinar

We are passionate about your success. Tell us more about your regulatory and quality needs to learn about how we can help.

Book a Consultation


To display custom copy instead of global copy in this section, please go to Show Global Content for Bottom CTA? toggle in the "Contents" tab to the left, toggle it off, save, and then REFRESH the page editor, the custom text will then show up and ready to be edited.

Turning the global content back on will be the same process, go to the toggle and toggle it back on, save and refresh!